These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15647215)

  • 21. Prophylactic defibrillator implantation--toward an evidence-based approach.
    Kadish A
    N Engl J Med; 2005 Jan; 352(3):285-7. PubMed ID: 15659729
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost-effectiveness of implantable cardioverter-defibrillators.
    Boriani G; Biffi M; Martignani C; Gallina M; Branzi A
    Eur Heart J; 2001 Jun; 22(12):990-6. PubMed ID: 11428834
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death.
    Henyan NN; White CM; Gillespie EL; Smith K; Coleman CI; Kluger J
    J Intern Med; 2006 Nov; 260(5):467-73. PubMed ID: 17040253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost of implantable defibrillators: perceptions and reality.
    Camm J; Klein H; Nisam S
    Eur Heart J; 2007 Feb; 28(4):392-7. PubMed ID: 16887857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shock treatment. Medicare's coverage of implantable defibrillators adds jolt to electrophysiology specialty, device sales.
    Becker C
    Mod Healthc; 2005 May; 35(19):34, 36. PubMed ID: 15929257
    [No Abstract]   [Full Text] [Related]  

  • 26. Referring patients for consideration of device treatment of sudden cardiac death and heart failure: incorporating evidence-based therapies within the Canadian health care system.
    Gillis AM
    Can J Cardiol; 2005 May; 21 Suppl A():25A-30A. PubMed ID: 15953941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons learned from neutral ICD trials.
    Nisam S; Breithardt G
    Europace; 2006 Jun; 8(6):393-7. PubMed ID: 16670114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of preimplantation cardiac imaging in patients referred for a primary-prevention implantable cardioverter-defibrillator.
    Krahn AD; Hoch JS; Rockx MA; Leong-Sit P; Gula LJ; Yee R; Skanes AC; Klein GJ
    Am J Cardiol; 2008 Sep; 102(5):588-92. PubMed ID: 18721517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary prevention of sudden death - afraid of the truth].
    Klein H
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2113. PubMed ID: 12397556
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)".
    Boriani G; Biffi M; Martignani C
    Circulation; 2005 Jan; 111(3):e26; author reply e26. PubMed ID: 15668348
    [No Abstract]   [Full Text] [Related]  

  • 31. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
    Al-Khatib SM; Sanders GD; Mark DB; Lee KL; Bardy GH; Bigger JT; Buxton AE; Connolly S; Kadish A; Moss A; Feldman AM; Ellenbogen KA; Singh S; Califf RM;
    Am Heart J; 2005 Jun; 149(6):1020-34. PubMed ID: 15976783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expenditure and value for money: the challenge of implantable cardioverter defibrillators.
    Boriani G; Biffi M; Martignani C; Diemberger I; Valzania C; Bertini M; Branzi A
    QJM; 2009 May; 102(5):349-56. PubMed ID: 19276209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare coverage for technological innovations--time for new criteria?
    Gillick MR
    N Engl J Med; 2004 May; 350(21):2199-203. PubMed ID: 15152067
    [No Abstract]   [Full Text] [Related]  

  • 34. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study.
    Passman R; Subacius H; Ruo B; Schaechter A; Howard A; Sears SF; Kadish A
    Arch Intern Med; 2007 Nov; 167(20):2226-32. PubMed ID: 17998496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.
    Toma M; McAlister FA; Ezekowitz J; Kimber S; Gulamhusein S; Pantano A; Sivakumaran S; Cujec B; Paterson I; Armstrong PW
    Am J Cardiol; 2006 Mar; 97(6):882-5. PubMed ID: 16516594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implanted cardioverter defibrillators for the prevention of sudden death.
    Dorian P; Talajic M; Tang A
    Can J Cardiol; 2005 May; 21 Suppl A():31A-36A. PubMed ID: 15953942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in hospitalization for the implantation of cardioverter-defibrillators in the United States, 1990-2005.
    Brown DW; Croft JB; Greenlund KJ; Mensah GA; Giles WH
    Am J Cardiol; 2008 Jun; 101(12):1753-5. PubMed ID: 18549853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.
    Yarnoz MJ; Curtis AB
    Cardiol Rev; 2006; 14(6):292-8. PubMed ID: 17053376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Special report: cost-effectiveness of implantable cardioverter-defibrillators in a MADIT-II population.
    Technol Eval Cent Assess Program Exec Summ; 2004 Apr; 19(3):1-2. PubMed ID: 15314827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.